0001683168-24-002047.txt : 20240401 0001683168-24-002047.hdr.sgml : 20240401 20240401213609 ACCESSION NUMBER: 0001683168-24-002047 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearson Mark E. CENTRAL INDEX KEY: 0001486558 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 24812017 MAIL ADDRESS: STREET 1: 3031 TISCH WAY STREET 2: SUITE 505 CITY: SAN JOSE STATE: CA ZIP: 95128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Altamont Pharmaceutical Holdings, LLC CENTRAL INDEX KEY: 0001745878 ORGANIZATION NAME: STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 24812018 BUSINESS ADDRESS: STREET 1: 3031 TISCH WAY STREET 2: SUITE 505 CITY: SAN JOSE STATE: CA ZIP: 95128 BUSINESS PHONE: (408) 479-7842 MAIL ADDRESS: STREET 1: 3031 TISCH WAY STREET 2: SUITE 505 CITY: SAN JOSE STATE: CA ZIP: 95128 FORMER NAME: FORMER CONFORMED NAME: Altamont Phamaceutical Holdings, LLC DATE OF NAME CHANGE: 20180709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 5 1 ownership.xml X0508 5 2023-12-31 1 0 1 0001563577 Galera Therapeutics, Inc. GRTX 0001745878 Altamont Pharmaceutical Holdings, LLC 5960 BERKSHIRE LN FLOOR 6 DALLAS TX 75225 0 0 1 0 0001486558 Pearson Mark E. 5960 BERKSHIRE LN FLOOR 6 DALLAS TX 75225 0 0 0 1 See footnote 1 below 1 Common Stock 2024-01-11 2024-01-11 4 S 0 L 400000 0.2256 D 4880000 I See fn. Common Stock 2024-03-22 2024-03-22 4 S 0 L 20000 0.23 D 4860000 I See fn. Common Stock 2024-03-25 2024-03-25 4 S 0 L 780000 0.2189 D 4080000 I See fn. Common Stock 2024-03-26 2024-03-26 4 S 0 L 2000000 0.1965 D 2080000 I See fn. Common Stock 2024-03-27 2024-03-27 4 S 0 L 306924 0.1699 D 1773076 I See fn. Common Stock 2024-03-28 2024-03-28 5 S 0 693076 0.1459 D 1080000 I See fn. Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC ("Altamont"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares. /s/ Mark Pearson, Manager of Altamont Pharmaceutical Holdings, LLC 2024-04-01 /s/ Mark Pearson 2024-04-01